2-[1-methyl-3-[3-[3-(3-methyl-5-pyridin-2-yl-2H-imidazol-1-yl)phenoxy]phenyl]-2H-imidazol-4-yl]pyridine
C30H28N6O — CID 140731099
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[1-methyl-3-[3-[3-(3-methyl-5-pyridin-2-yl-2H-imidazol-1-yl)phenoxy]phenyl]-2H-imidazol-4-yl]pyridine
2-[1-methyl-3-[3-[3-(3-methyl-5-pyridin-2-yl-2H-imidazol-1-yl)phenoxy]phenyl]-2H-imidazol-4-yl]pyridine (PubChem CID 140731099) has the molecular formula C30H28N6O and a molecular weight of 488.60 g/mol. Its IUPAC name is 2-[1-methyl-3-[3-[3-(3-methyl-5-pyridin-2-yl-2H-imidazol-1-yl)phenoxy]phenyl]-2H-imidazol-4-yl]pyridine.
Molecular Properties
| Compound Name | 2-[1-methyl-3-[3-[3-(3-methyl-5-pyridin-2-yl-2H-imidazol-1-yl)phenoxy]phenyl]-2H-imidazol-4-yl]pyridine |
|---|---|
| PubChem CID | 140731099 |
| Molecular Formula | C30H28N6O |
| Molecular Weight | 488.60 g/mol |
| Exact Mass | 488.23 |
| IUPAC Name | 2-[1-methyl-3-[3-[3-(3-methyl-5-pyridin-2-yl-2H-imidazol-1-yl)phenoxy]phenyl]-2H-imidazol-4-yl]pyridine |
| SMILES | CN1C=C(c2ccccn2)N(c2cccc(Oc3cccc(N4CN(C)C=C4c4ccccn4)c3)c2)C1 |
| InChI | InChI=1S/C30H28N6O/c1-33-19-29(27-13-3-5-15-31-27)35(21-33)23-9-7-11-25(17-23)37-26-12-8-10-24(18-26)36-22-34(2)20-30(36)28-14-4-6-16-32-28/h3-20H,21-22H2,1-2H3 |
| InChIKey | PTDZUJGZWMTDFY-UHFFFAOYSA-N |
| XLogP | 5.68 |
| TPSA | 47.97 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 488.60 |
| LogP ≤ 5 | 5.68 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 140731099 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.